| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2023 | — | Benchmark | Downgrades | Buy → Hold | |
| 06/13/2023 | 13.14% | UBS | $33 → $15.5 | Downgrades | Buy → Neutral |
| 01/09/2023 | 82.48% | Goldman Sachs | → $25 | Upgrades | Neutral → Buy |
| 09/02/2022 | 60.58% | HSBC | $26 → $22 | Maintains | Hold |
| 08/15/2022 | — | OTR Global | Downgrades | Mixed → Negative | |
| 06/02/2022 | 89.78% | HSBC | $31 → $26 | Maintains | Hold |
| 05/18/2022 | 211.68% | CLSA | $45 → $42.7 | Maintains | Buy |
| 03/11/2022 | 102.92% | UBS | $64 → $27.8 | Downgrades | Buy → Neutral |
| 03/04/2022 | 155.47% | 86 Research | → $35 | Upgrades | Hold → Buy |
| 03/04/2022 | 308.76% | Benchmark | $70 → $56 | Maintains | Buy |
| 08/20/2021 | 272.26% | HSBC | $40 → $51 | Upgrades | Reduce → Hold |
| 08/19/2021 | 308.76% | Credit Suisse | $48 → $56 | Upgrades | Neutral → Outperform |
| 06/26/2020 | 206.57% | B of A Securities | → $42 | Initiates Coverage On | → Buy |
| 05/21/2020 | 199.27% | Nomura | $43 → $41 | Maintains | Neutral |
| 04/22/2020 | 191.97% | Barclays | $47 → $40 | Downgrades | Overweight → Equal-Weight |
| 02/27/2020 | 264.96% | Benchmark | $51 → $50 | Maintains | Buy |
| 02/27/2020 | 232.12% | UBS | $46.5 → $45.5 | Maintains | Neutral |
| 02/24/2020 | 250.36% | Barclays | $50 → $48 | Maintains | Overweight |
| 11/15/2019 | — | CLSA | Downgrades | Buy → Outperform | |
| 10/18/2019 | 330.66% | Jefferies | → $59 | Upgrades | Hold → Buy |
| 10/04/2019 | — | Credit Suisse | Upgrades | Neutral → Outperform | |
| 08/05/2019 | 218.25% | Jefferies | → $43.6 | Initiates Coverage On | → Hold |
| 07/17/2019 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 05/28/2019 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 05/24/2019 | — | HSBC | Downgrades | Hold → Reduce | |
| 03/06/2019 | — | China Renaissance | Downgrades | Buy → Hold | |
| 01/24/2019 | 323.36% | Jefferies | $83 → $58 | Downgrades | Buy → Hold |
| 01/22/2019 | 345.26% | Nomura | $74 → $61 | Downgrades | Buy → Neutral |
| 01/08/2019 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 08/29/2018 | 761.31% | JP Morgan | $142 → $118 | Maintains | Overweight |
What is the target price for Weibo (WB)?
The latest price target for Weibo (NASDAQ: WB) was reported by Benchmark on August 25, 2023. The analyst firm set a price target for $0.00 expecting WB to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Weibo (WB)?
The latest analyst rating for Weibo (NASDAQ: WB) was provided by Benchmark, and Weibo downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Weibo (WB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Weibo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Weibo was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.
Is the Analyst Rating Weibo (WB) correct?
While ratings are subjective and will change, the latest Weibo (WB) rating was a downgraded with a price target of $0.00 to $0.00. The current price Weibo (WB) is trading at is $13.70, which is out of the analyst's predicted range.